Request Deal Involvement

Bausch + Lomb completed the acquisition of XIIDRA from Novartis for $2.5bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

JP Morgan

debt providers

JP Morgan

JP Morgan

financial advisors

JP Morgan

Wachtell Lipton Rosen & Katz

legal advisors

Wachtell Lipton Rosen & Katz

Davis Polk & Wardwell

legal advisors

Davis Polk & Wardwell

Simpson Thacher & Bartlett

legal advisors to debt providers

Simpson Thacher & Bartlett

Evercore

financial advisors

Evercore

Covington & Burling

legal advisors

Covington & Burling

or

Principals

XIIDRA

target

XIIDRA

BAUSCH + LOMB

bidder

BAUSCH + LOMB

NOVARTIS AG

vendor

NOVARTIS AG

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite